Population clinical pharmacology of children: general principles.

作者: Brian J. Anderson , Karel Allegaert , Nicholas H. G. Holford

DOI: 10.1007/S00431-006-0188-Y

关键词:

摘要: Population modelling using mixed-effects models provides a means to study variability in drug responses among individuals representative of those for whom the will be used clinically. The advantages these paediatric studies are that they can analyse sparse data, sampling times not crucial and fitted around clinical procedures with missing data may still included analysis. introduction explanatory covariates explains predictable part between-individual variability. Simulations parameter estimates their investigate large numbers children – many more than is possible dealing real fraction cost, which an advantage when developing trials. Paediatric population has expanded greatly past decade now routine procedure during development investigation drugs. Children have benefitted continue benefit from this approach.

参考文章(45)
Stephen B. Duffull, [edited by] Hui C. Kimko, Simulation for designing clinical trials : Marcel Dekker. ,(2003)
Thaddeus H. Grasela Jr., Steven M. Donn, Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data Developmental pharmacology and therapeutics. ,vol. 8, pp. 374- 383 ,(1985) , 10.1159/000457062
Peter L. Bonate, The effect of collinearity on parameter estimates in nonlinear mixed effect models. Pharmaceutical Research. ,vol. 16, pp. 709- 717 ,(1999) , 10.1023/A:1018828709196
Bideshwar K. Kataria, Sudha A. Ved, Honorato F. Nicodemus, Gregory R. Hoy, Dawn Lea, Michel Y. Dubois, Jaap W. Mandema, Steven L. Shafer, The Pharmacokinetics of Propofol in Children Using Three Different Data Analysis Approaches Anesthesiology. ,vol. 80, pp. 104- 122 ,(1994) , 10.1097/00000542-199401000-00018
Carl C. Peck, Stuart L. Beal, Lewis B. Sheiner, Alice I. Nichols, Extended least squares nonlinear regression: A possible solution to the “choice of weights” problem in analysis of individual pharmacokinetic data Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 12, pp. 545- 558 ,(1984) , 10.1007/BF01060132
Ralph E. Kauffman, Fentanyl, fads, and folly: who will adopt the therapeutic orphans? The Journal of Pediatrics. ,vol. 119, pp. 588- 589 ,(1991) , 10.1016/S0022-3476(05)82409-6
Ann Pariente-Khayat, Elisabeth Rey, Dominique Gendrel, Françoise Vauzelle-Kervroëdan, Odile Crémier, Philippe d'Athis, Jean Badoual, Georges Olive, Gérard Pons, Isoniazid acetylation metabolic ratio during maturation in children. Clinical Pharmacology & Therapeutics. ,vol. 62, pp. 377- 383 ,(1997) , 10.1016/S0009-9236(97)90115-6
Lewis B. Sheiner, Barr Rosenberg, Vinay V. Marathe, Estimation of population characteristics of pharmacokinetic parameters from routine clinical data Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 5, pp. 445- 479 ,(1977) , 10.1007/BF01061728
Brian J. Anderson, Gerald A. Woollard, Nicholas H. G. Holford, A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children British Journal of Clinical Pharmacology. ,vol. 50, pp. 125- 134 ,(2000) , 10.1046/J.1365-2125.2000.00231.X